Patients with certain malignancies or other disorders may benefit from a bone marrow transplant (BMT). A bone marrow transplant involves extracting cells from the donor's bone marrow (stem cells), screening them, and returning them to the donor (patient) or another person. After a person's own unhealthy bone marrow has been treated to eliminate the aberrant cells, BMT is used to transfuse healthy bone marrow cells into him or her. Since 1968, bone marrow transplantation has been used to treat diseases such leukemias, lymphomas, aplastic anaemia, immune deficiency syndromes, and various solid tumour malignancies.
Hematopoietic stem cell transplantation (HSCT) is an intravenous infusion of hematopoietic stem cells used to restore blood cell production in individuals with damaged or dysfunctional bone marrow or immune systems. This approach has been utilised to treat a variety of malignant and nonmalignant disorders with increasing frequency during the last half-century.
Title : Cellular mechanisms involved in seronegative hemolysis
Donald R Branch, University of Toronto, Canada
Title : Immuno-Oncology (IO): 2023 and beyond
Stefan Gluck, Global Medical Affairs at Celgene Corporation, United States
Title : Managing bacterial eradication in disease and survival for life support systems on earth and space
A C Matin, Stanford Medical School, United States
Title : Hereditary hemolytic anemias due to red blood cell membranopathies rheological and genetic approach
Joan LLuis Vives Corrons, University of Barcelona, Spain
Title : The complete evidence that starling’s law responsible for many errors and misconceptions on fluid therapy in shock is wrong: The correct replacement is the hydrodynamic phenomenon of the porous orifice (G) tube
Ahmed N Ghanem, Mansoura University, Egypt
Title : Breaking Down Mental Health Stigmas
Thad Cummings, Thad Cummings, United States